ASAnders Stouge

Anders Stouge

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anders Stouge has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Impact of obesity and type 2 diabetes on muscle power, quality, and force–velocity, and their relation to functional capacity

    by Anders Stouge, Anders Hammer Nielsen-Kudsk, Michael Vaeggemose, Hatice Tankisi, Jens Meldgaard Bruun, Henning Andersen

    Background: Obesity and type 2 diabetes (T2D) increase the risk of sarcopenia and mobility decline, yet the underlying muscle contractile alterations remain poorly understood. This study investigated how severe obesity and T2D affect muscle power, force–velocity relationships, and muscle quality. Methods: In this cross-sectional study, 45 middle-aged individuals were categorized as non-obesity (Non-O; BMI 18.5–30 kg/m 2 ), obesity (O; BMI ≥ 35 kg/m 2 ), and obesity with T2D (O + T2D; BMI ≥ 35 kg/m 2 ). Isokinetic torque and power of knee extensors (KE) and dorsiflexors (DF) were measured (DF: 0–120°/s; KE: 0–270°/s). Muscle volume and fat infiltration (FF, %) were quantified using MRI. Outcomes included absolute, specific (relative to muscle volume), and normalized (relative to body weight) power. Functional capacity was assessed with five-times sit-to-stand (5xSTS) and 10-m walk (10MWT) tests. Results: KE power was 51W lower in O + T2D than O (P = 0.008) with larger deficits at higher velocities (interaction, P = 0.027). O and O + T2D exhibited lower normalized KE power (–0.8 and –1.1 W/kg vs. Non-O; both P < 0.001). KE FF was higher in O (5%) than Non-O (3%, P = 0.003), and highest in O + T2D (7%, P = 0.023). DF torque declined faster with velocity in O and O + T2D (P ≤ 0.012). Specific power did not differ. KE normalized power was the strongest predictor of performance (5xSTS: R 2 = 0.57,P = 0.003; 10MWT: R 2 = 0.71,P < 0.001). Conclusions: Severe obesity impairs normalized muscle power, with T2D exacerbating KE power deficits and fatty infiltration. These muscle contractile impairments may contribute to functional decline already in middle-aged individuals.


  • Ketone Monoester Increases Skeletal Muscle Power and Energy Turnover in Older but Not Young Men Without Affecting Metabolic Economy: A Controlled, Double Blind, Cross‐Over Trial

    by Ole Emil Andersen, Ryan Godsk Larsen, Niels Møller, Anders Stouge, Steffen Ringgaard, Kristian Overgaard, Niels Jessen

    Aim: Ketosis may represent a therapeutic target for age‐related impairments in skeletal muscle function. This study investigated acute effects of ketosis on metabolic economy, mitochondrial function, and contractile parameters in skeletal muscle of young and older adults. Methods: Twelve young (20–25 years) and twelve older (65–85 years) healthy men, matched by age‐adjusted V̇O 2 max, participated in a randomized, crossover, double‐blind intervention with ingestion of ketone monoester or placebo on separate study days. On both days, a low‐dose, continuous glucose infusion blocked endogenous ketone production. Metabolic economy, oxidative capacity, muscle performance, intramuscular pH, and relative decline in peak power were assessed in the tibialis anterior through phosphorous MR spectroscopy ( 31 P‐MRS) and dynamometer recordings. Mitochondrial function of the quadriceps femoris muscle was assessed by high‐resolution respirometry. Results: Ketosis had no effect on metabolic economy in either young or older participants. The older group showed lower metabolic economy compared to the young group. In older participants, ketones increased ATP production and time‐torque derived work capacity. Oxidative capacity was similar between groups and remained unaffected by ketones. In the older group, ketones improved peak power and increased both muscle relative decline in peak power and contraction‐induced pH decline. Complex I + II respiration was lower in older compared to young participants, with no effect of ketones. Conclusion: Ketosis enhanced skeletal muscle work capacity and ATP production in older but not young adults, suggesting an age‐specific effect of ketone bodies on muscle function that operates independently of changes in metabolic economy and mitochondrial function. These findings support ketosis as a promising ergogenic therapy for older adults. Trial Registration: The study was pre‐registered at clinicaltrials.gov (NCT05732909)


  • Open Access

    High-frequency nerve ultrasound in Guillain-Barré syndrome

    by Jesper Helbo Storgaard, Erisela Qerama, Anders Stouge, Hatice Tankisi, Thomas Harbo, Henning Andersen, Lotte Levison

  • Open Access

    Accuracy and reliability of an MR-compatible dorsiflexion ergometer for dynamic 31P-MRS: Comparison with a clinical dynamometer in individuals with and without obesity

    by Anders Stouge, Ole Emil Andersen, Esben Søvsø Szocska Hansen, Cuno Rasmussen, Ryan Godsk Larsen, Gwenael Layec, Jack Miller, Ladislav Valkovič, Jane A. Kent, Christoffer Laustsen, et al.

    Background: The clinical application of MR-compatible ergometers for muscle contractile assessment is limited by a lack of validation against standard clinical dynamometers. Moreover, the impact of obesity on the reliability of MR ergometer-based muscle contractile assessments and the quality of phosphorus-31 magnetic resonance spectroscopy ( 31 P-MRS) data remains unclear. This study aimed to validate an MR-compatible ergometer against a clinical dynamometer and to evaluate the applicability of 31 P-MRS in individuals with severe obesity. Methods: Twenty adults (35–60 years) were recruited and divided into groups of non-obese (BMI 18.5-30 kg/m 2 , n=10) and severely obese (BMI ≥35 kg/m², n=10), matched for age, sex, and height. Ankle dorsiflexion was assessed using both a clinical dynamometer and an MR ergometer, measuring maximal voluntary isometric contraction (MVIC) and a 4-minute isotonic fatiguing exercise. 31 P-MRS was continuously acquired during the in-scanner exercise. Agreement between devices was assessed using Bland-Altman plots and intraclass correlation coefficients (ICCs). 31 P-MRS data quality was evaluated based on signal-to-noise ratio (SNR), uncertainty of fit (CRLB), and phosphocreatine (PCr) recovery fit (R 2 ). Pearson’s correlations examined relationships between muscle fatigue and metabolic parameters. Results: All subjects successfully completed the protocol on both devices. The MR ergometer demonstrated moderate-to-excellent reliability (ICC ≥0.50) for most contractile parameters. While maximal torque, power, and work were underestimated on the MR ergometer (16-28%), this bias was consistent across BMI groups. 31 P-MRS met preset quality thresholds (SNR≥5, CRLB 2 ≥0.70) in both groups. Dorsiflexion fatigue (reduction in power) correlated strongly (r ≥0.77) with metabolic changes, including PCr depletion (R²=0.68), pH drop (R²=0.59), PCr recovery time constant (R²=0.62), and inorganic phosphate accumulation (Pi/PCr) (R²=0.67). Conclusion: The MR ergometer demonstrated feasibility, acceptable reliability, and consistent 31 P-MRS data quality across BMI groups. These findings support the use of the MR ergometer for in-scanner dorsiflexor assessments, even in individuals with severe obesity.

  • MRI of Skeletal Muscles in Participants with Type 2 Diabetes with or without Diabetic Polyneuropathy

    by Anders Stouge, Karolina S. Khan, Alexander G. Kristensen, Hatice Tankisi, Lara Schlaffke, Martijn Froeling, Michael Væggemose, Henning Andersen

    Lower extremity MRI, including the Dixon sequence, T2 relaxation of muscle, and fractional anisotropy, depicted fat accumulation, change in muscle water content, and structure in participants with ... BackgroundDiabetic polyneuropathy (DPN) is associated with loss of muscle strength. MRI including diffusion-tensor imaging (DTI) may enable detection of muscle abnormalities related to type 2 diabe...